vTv Therapeutics Inc (VTVT)
23.72
-1.02
(-4.12%)
USD |
NASDAQ |
Apr 19, 15:35
vTv Therapeutics Shareholders Equity (Quarterly): -24.68M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.68M |
| September 30, 2023 | -25.23M |
| June 30, 2023 | -25.28M |
| March 31, 2023 | -19.19M |
| December 31, 2022 | -10.74M |
| September 30, 2022 | -16.57M |
| June 30, 2022 | -8.526M |
| March 31, 2022 | -8.093M |
| December 31, 2021 | -9.74M |
| September 30, 2021 | -21.54M |
| June 30, 2021 | -47.82M |
| March 31, 2021 | -56.28M |
| December 31, 2020 | -80.10M |
| September 30, 2020 | -51.37M |
| June 30, 2020 | -69.53M |
| March 31, 2020 | -61.82M |
| December 31, 2019 | -49.02M |
| September 30, 2019 | -47.15M |
| June 30, 2019 | -49.90M |
| Date | Value |
|---|---|
| March 31, 2019 | -57.74M |
| December 31, 2018 | -82.85M |
| September 30, 2018 | -43.98M |
| June 30, 2018 | -71.60M |
| March 31, 2018 | -148.79M |
| December 31, 2017 | -151.05M |
| September 30, 2017 | -136.30M |
| June 30, 2017 | -106.41M |
| March 31, 2017 | -123.47M |
| December 31, 2016 | -90.94M |
| September 30, 2016 | -111.24M |
| June 30, 2016 | -79.52M |
| March 31, 2016 | -63.02M |
| December 31, 2015 | -77.97M |
| September 30, 2015 | -94.18M |
| June 30, 2015 | -80.94M |
| March 31, 2015 | -70.53M |
| December 31, 2014 | -60.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-80.10M
Minimum
Dec 2020
-8.093M
Maximum
Mar 2022
-35.93M
Average
-25.28M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Altimmune Inc | 194.10M |
| Palatin Technologies Inc | -11.38M |
| Oragenics Inc | 3.168M |
| Viking Therapeutics Inc | 348.42M |
| G1 Therapeutics Inc | 35.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.02M |
| Total Liabilities (Quarterly) | 29.57M |